Notice: Revision to the Guidance Document: Management of Drug Submissions and Applications

Health Canada is revising the Guidance Document entitled: The Management of Drug Submissions and Applications (MDSA). This document provides sponsors and Health Canada staff of the Therapeutic Products Directorate, the Biologic and Radiopharmaceutical Drugs Directorate, the Natural and Non-Prescription Health Products Directorate (Non-Prescription Drugs Evaluation Division), and the Marketed Health Products Directorate with operational direction and guidance regarding the way in which drug submissions, applications or post-market documents submitted to Health Canada are managed.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2021-12-29

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data